NetworkNewsBreaks – ABcann Global Corporation (T
Post# of 111
ABcann Global Corporation (TSXV: ABCN) yesterday announced its inclusion in the Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ). The ETF is a first-of-its-kind index offering investors direct exposure to a basket of North American life sciences companies with significant business activities in the medical marijuana sector. “The Horizons ETF represents a new type of investment, a fund that tracks an industry in which there is considerable interest but which had no prior investment vehicle through which investors could gain broad exposure,” Aaron Keay, CEO of ABcann, stated in the news release. “Our inclusion in the ETF represents an important milestone for our company as we strive to become a dominant industry participant.” Moving forward, stocks will be rebalanced quarterly on a market-capitalization basis, with a cap in place to ensure that no single stock can exceed 10 percent of the weight of the ETF when rebalanced. Only stocks that meet minimum asset and liquidity thresholds will be eligible for inclusion in the index.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer